EFFECTS OF SARCOPENIA AND SARCOPENIC OBESITY ON THE HEALTH STATUS OF ELDERLY POPULATION

  • Irina Mihaela ABDULAN “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Adina Carmen ILIE “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Ioana Alexandra SANDU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Anca Iuliana PISLARU “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Abstract

Sarcopenic obesity (SO) is a category of obesity that occurs predominantly in elderly people who experience an increase in adipose tissue associated with muscle mass loss. It is associated with higher mortality rates than sarcopenia and obesity alone, thus confirming the need to redefine obesity and sarcopenia based on the new parameters-the simple determination of the body mass index becoming unsatisfactory. Quantification of obesity is done by measuring through various imaging techniques the percentage of fat mass, muscle mass/lean body tissue and bone mass or the ratio of visceral fat to thigh muscle area (determined by computed tomography). Redefinition of sarcopenia is a decrease in striated muscle mass associated with either a decrease in muscle strength (hand grip strength) or reduced physical activity ("gait speed"); when all three criteria are met, we talk of severe sarcopenia. These new parameters result from the fact that in sarcopenia there is no parallel loss of muscle mass and muscle strength, and that the alteration of muscle strength is a more important risk factor for overall mortality than the decline in muscle mass. For these reasons, quantification of the degree of sarcopenia is done by individual assessment of the three parameters: muscle mass, muscle strength and physical activity. Although currently there is no consensus on the definition of SO, all authors agree on its serious consequences on the quality of life of the elderly, favoring cardiovascular and metabolic diseases, aggravating frailty, significantly increasing the risk of falling and of developing disabilities, and finally, increase in overall mortality. Today, SO identification, prevention and treatment become priority interventions in the therapeutic plan of the elderly to ensure successful aging and maintain a quality of life corresponding to expectations.

Author Biographies

Irina Mihaela ABDULAN, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (II)

Adina Carmen ILIE, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (II)
“Dr. C. I. Parhon” Clinical Hospital Iasi

Ioana Alexandra SANDU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (II)
“Dr. C. I. Parhon” Clinical Hospital Iasi

Anca Iuliana PISLARU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (II)
“Dr. C. I. Parhon” Clinical Hospital Iasi

References

1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boyrie Y, Cederholm T, Landi F et al. Sarcopenia: European consensus on definition and diagnosis; Report of the European Working Group on Sarcopenia in older people. Age Ageing 2010; 39 (4): 1-12.
2. Baumgartner RN. Body composition in healthy aging. Ann NY Acad Sci 2000; 904: 437-448.
3. Wannamethee SG, Atkins JL. Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity. Proc Nutr Soc 2015; 74: 405-412.
4. Kyung Mook Choi Sarcopenia and sarcopenic obesity. Korean J Intern Med 2016; 31(6): 1054-1060.
5. Lim KI, Yang SJ, Kim TN, et al. The association between the ratio of visceral fat to thigh muscle area and metabolic syndrome: the Korean Sarcopenic Obesity Study (KSOS). Clin Endocrinol (Oxf) 2010; 73: 588-594.
6. Goisser S, Kemmler W, Porzel S, et al. Sarcopenic obesity and complex interventions with nutrition and exercise in community-dwelling older persons - a narrative review. Clin Interv Aging 2015; 10: 1267-1282.
7. Alagiakrishnan K, Banach M, Ahmed A, Aronov WS. Complex relationship of obesity and obesity paradox in heart failure - higher risk of developing heart failure and better outcomes in established heart failure. Ann Med 2016; 48(8): 603-613.
8. Crăcană IM, Ştefăniu R, Mocanu V et al. New developments in the approach and diagnosis of sarcopenia. Rev Med Chir Soc Med Nat Iasi 2016; 120(3): 491-496.
9. Rosenberg I. Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr 1989; 50: 1231-1233.
10. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al. Sarcopenia: European consensus on definition and diagnosis. Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39(4): 412-423.
11. Bellanti F, Romano AD, Lo Buglio A, et al. Oxidative stress is increased in sarcopenia and associated with cardiovascular disease risk in sarcopenic obesity. Maturitas 2018; 109: 6-12.
12. Arcan O, Bild W, Ciobica A, Serban DN, Anton E, Petrariu F, Timofte D, Nastasa V. Angiotensin- (1-7) intracerebroventricular administration generates nociceptive effects in hot-plate task and decreased oxidative stress in the temporal lobe. Romanian Biotechnological Letters 2014; 19(5): 9763-9771.
13. White TA, LeBrasseur NK. Myostatin and sarcopenia: opportunities and challenges: a mini-review. Gerontol 2014; 60: 289-293.
14. Trofin FP, Chirazi M, Honceriu C, Drosescu P, Gradinariu G, Vorniceanu A, Anton E, Cojocaru D, Ciobica A, Ciornea E et al. Pre-administration of vitamin c reduces exercise-induced oxidative stress in untrained subjects. Archives of biological sciences 2014; 66(3): 1179-1185.
15. Cederholm T, Morley JE. Sarcopenia: the new definitions. Curr Opin Clin Nutr Metab Care 2014; 18(1): 1-4.
16. Filippin LI, Teixeira VN, da Silva MP, Miraglia F, da Silva FS. Sarcopenia: a predictor of mortality and the need for early diagnosis and intervention. Aging Clin Exp Res. 2015; 27: 249-254.
17. Delmonico MJ, Harris TB, Lee JS et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 2007; 55(5): 769-774.
18. Cepoi V, Alexa ID, Ilie CA, Alexa O. Ethical dilemmas in treating elderly patients at risk of polypragmasy and polypharmacy. Rev Romana de Bioetica 2014; 12(3): 12-18.
19. Kim TN, Park MS, Ryu JY et al. Impact of visceral fat on skeletal muscle mass and vice versa in a prospective cohort study: the Korean Sarcopenic Obesity Study (KSOS) PLoS One. 2014;9.
20. Pîslaru AI, Ilie AC, Pancu AG, Sandu IA, Alexa ID. Detection and prevention of frailty in independently living pre-elderly and elderly in Northeastern Romania. Rev Med Chir Soc Med Nat Iasi 2016; 120(4): 909-914.
21. Perna S, Peroni G, Faliva MA, et al. Sarcopenia and sarcopenic obesity in comparison: prevalence, metabolic profile, and key differences. A cross-sectional study in Italian hospitalized elderly. Aging Clin Exp Res 2017; 29(6): 1249-1258.
22. Stefaniu R, Abdulan I, Alexa T, Mastaleru A, Alexa ID, Astărăstoae V. Successful aging is influenced by frailty and health related quality of life in community-dwelling seniors. Rev Med Chir Soc Med Nat Iasi 2017; 121(1): 104-111.
23. Tian S, Xu Y. Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies. Geriatr Gerontol Int. 2016; 16: 155-166.
24. Kim JH, Cho JJ, Park YS. Relationship between Sarcopenic Obesity and Cardiovascular Disease Risk as Estimated by the Framingham Risk Score. J Korean Med Sci 2015; 30(3): 264-271.
25. Jang HC. Sarcopenia, frailty, and diabetes in older adults. Diabetes Metab J. 2016; 40: 182-189.
26. Solerte SB, Gazzaruso C, Bonacasa R et al. Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia. Am J Cardiol 2008; 101: 69E-77E.
27. Costin H, Cehan V, Rotariu C et al. TELEMON - A Complex System for Real Time Telemonitoring of Chronic Patients and Elderly People. Edited by Vander Sloten J, Verdonk P, Nyssen M et al. The 4th European Conference of the International Federation for Medical and Biological Engineering (ECIFMBE), Antwerp, 2008.
28. Van Aller C, Lara J, Stephan BCM et al. Sarcopenic obesity and overall mortality: Results from the application of novel models of body composition phenotypes to the National Health and Nutrition Examination Survey 1999-2004. Clin Nutr 2018; pii: S0261-5614(18)30042-6.
Published
2018-06-29
Section
INTERNAL MEDICINE - PEDIATRICS